CRITICAL CHALLENGESfor Multilingual Clinical Label Management

Clinical trials are currently underway in 200+ countries.

The move to globalization has made accurate and effective mul-tilingual clinical labeling critical to meeting patient, clinician, supply

chain and regulatory needs.

WARNING: Clinical label translation

and compliance mistakes are costly and can jeopardize your

entire trial.

47%36%

Shorter Production Timelines

for a greater variety of label types, in more languages

Demanding Processwith 1000s of moving parts can overwhelm the most

robust organizations

Errors and Inconsistenciesfrom multiple vendors across

multisite studies lead to regulatory mistakes and translation errors

OUTCOMESStreamlined, scalable process

for global clinical labels

STREAMLINE MULTIPLE

VENDORS & PROCESSES

Speed turnaround times

Reduce cost and risk

Increase total quality

Remove internal distractions

CENTRALIZATION

LIFESCIENCES. L IONBRIDGE.COMREADY TO LEARN MORE?

Greater Efficienciesoptimized process for speed,

scale, quality

Financial Savingslabels and submissions right

the first time

Patient Healthaccuracy and consistency

for 250+ languages

GLOBAL CLINICAL TRIALS

Almost half take place outside of the US, including emerging countries who are heavily investing in healthcare and life sciences infrastructure.

Testing and approval are now set upon a global path, which serves both developers and diverse patient populations.

REGISTERED TRIALSas of May 2017 clinicaltrials.gov

Non-US only US only Not provided Both US & Non-US